MedTrace Logo

Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol

NCT06223594 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-07-25

No results posted yet for this study

Summary

Acute pancreatitis (AP) is a common disease of the gastrointestinal tract that can result in emotional, physical, and financial burdens on the patient.

Conditions

Interventions

OTHER

Intravenous Fluid Therapy

Evaluate the safety and efficacy of the Dallas acute pancreatitis protocol(DAPP) order set on Acute pancreatitis(AP) patients receiving aggressive, goal-directed Intravenous fluid(IVF )therapy.

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Jessica Crotty, PharmD · Methodist Midlothian Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2025-07-22
Completion
2025-07-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06223594 on ClinicalTrials.gov